Daniel Pak, MD
Pain Medicine · Houston, TXNPI 1558705301
Payments from drug & device makers
Across 385 payments — averaging $1194.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$344K
- Nevro Corp.$28K
- GRT US Holding, Inc.$25K
- Globus Medical$17K
- Averitas Pharma Inc.$17K
- MML US, Inc.$14K
- plus $15K from 15 others
What the payments were for
- Consulting fees$21,73619%
- Speaking & faculty fees$59,69651%
- Grants$980%
- Travel & lodging$19,68317%
- Food & beverage$15,83214%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 42 | $344,145 |
| Nevro Corp. | 62 | $28,177 |
| GRT US Holding, Inc. | 58 | $24,825 |
| Globus Medical | 22 | $17,047 |
| Averitas Pharma Inc. | 26 | $16,611 |
| MML US, Inc. | 36 | $14,036 |
| Medtronic(2 entities) | 68 | $6,440 |
| Relievant Medsystems, Inc. | 22 | $2,760 |
| Vertos Medical, Inc. | 15 | $2,276 |
| Abbott | 9 | $1,029 |
| Stratus Medical, LLC | 7 | $930 |
| SPR Therapeutics, Inc | 6 | $568 |
| Biotronik NRO, Inc. | 3 | $219 |
| Saluda Medical Americas, Inc. | 2 | $217 |
| Si-bone, Inc. | 1 | $159 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $143 |
| Nalu Medical, Inc. | 1 | $140 |
| Gilead | 1 | $118 |
| Siemens Medical Solutions USA, Inc. | 1 | $93 |
| Vertex | 1 | $42 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$40,286
- Senza$34,894
- ReActiv8$13,339
- Intracept$9,336
- Omnia$8,117
- INTELLIS ADAPTIVESTIM$2,258
- mild Device Kit$1,916
- INTELLIS$994
- Senza Spinal Cord Stimulation System$854
- Nimbus$718
- PROCLAIM$449
- GENERAL PAIN MANAGEMENT$418
- SPRINT PNS System$280
- Evoke SCS$172
- Proclaim Family of SCS IPGs$172
- Prospera$150
- WaveWriter Alpha Prime 16$145
- RELISTOR$143
- CATALYFT PL EXPANDABLE INTERBODY SYSTEM$142
- Nalu Neurostimulation System$140
How this compares
$459,991 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 12 | $6,979 |
| Pregabalin | 61 | $1,458 |
| Diclofenac Sodium | 40 | $1,053 |
| Lidocaine | 11 | $888 |
| Gabapentin | 84 | $752 |
| Oxycodone Hcl | 35 | $545 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $496 |
| Celecoxib | 25 | $429 |
| Duloxetine Hcl | 26 | $343 |
| Methadone Hcl | 11 | $276 |
| Meloxicam | 39 | $156 |
| Methylprednisolone | 14 | $126 |
| Tramadol Hcl | 21 | $110 |
| Tizanidine Hcl | 15 | $104 |
| Cyclobenzaprine Hcl | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Houston
- Mitchell EngleHouston$1.5M
- David LeimanHouston$281K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Jaideep MehtaHouston$161K
- Mayur KanjiaHouston$46K
- Baominh VinhHouston$44K
- Matthew ChungHouston$26K
- Aaron CalodneyTyler$3M
- Melissa MurphyGrapevine$711K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.